Cargando…
A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
Adult vaccination is high on the agenda in many countries. Two different vaccines are available for the prevention of pneumococcal disease in adults: a 23-valent polysaccharide vaccine (PPV23), and a 13-valent conjugated vaccine (PCV13). The objective of this review is to update the evidence base fo...
Autores principales: | Berild, Jacob Dag, Winje, Brita Askeland, Vestrheim, Didrik Frimann, Slotved, Hans-Christian, Valentiner-Branth, Palle, Roth, Adam, Storsäter, Jann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238108/ https://www.ncbi.nlm.nih.gov/pubmed/32260132 http://dx.doi.org/10.3390/pathogens9040259 |
Ejemplares similares
-
The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children
por: Winje, Brita Askeland, et al.
Publicado: (2021) -
Cost-utility analysis of a universal pneumococcal vaccination programme for older adults in Norway
por: Nymark, Liv Solvår, et al.
Publicado: (2022) -
Gastrointestinal symptoms in invasive pneumococcal disease: a cohort study
por: Floeystad, Hans Kristian, et al.
Publicado: (2020) -
2592. The Incidence Rate Of Pneumococcal Pneumonia In Two European Aging Adults Population Using Real-World Data
por: López-lacort, Mónica, et al.
Publicado: (2023) -
Estimation of the incidence of hospitalisation for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older
por: Lyngstad, Trude Marie, et al.
Publicado: (2022)